Pathogenicity and comparative evolution in vivo of the transitional quasispecies SIVsmmPBj8.

PubWeight™: 0.78‹?›

🔗 View Article (PMID 10364501)

Published in Virology on June 20, 1999

Authors

B Tao1, P N Fultz

Author Affiliations

1: Department of Microbiology, University of Alabama School of Medicine, Birmingham, Alabama 35294, USA.

Articles by these authors

The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin. J Virol (1996) 3.82

Isolation of a T-lymphotropic retrovirus from naturally infected sooty mangabey monkeys (Cercocebus atys). Proc Natl Acad Sci U S A (1986) 3.76

HIV-1 Vpr increases viral expression by manipulation of the cell cycle: a mechanism for selection of Vpr in vivo. Nat Med (1998) 3.61

Sequence analysis and acute pathogenicity of molecularly cloned SIVSMM-PBj14. Nature (1990) 3.54

Effect of immunization with a vaccinia-HIV env recombinant on HIV infection of chimpanzees. Nature (1987) 2.82

Persistent infection of chimpanzees with human T-lymphotropic virus type III/lymphadenopathy-associated virus: a potential model for acquired immunodeficiency syndrome. J Virol (1986) 2.65

Protection against lethal simian immunodeficiency virus SIVsmmPBj14 disease by a recombinant Semliki Forest virus gp160 vaccine and by a gp120 subunit vaccine. J Virol (1996) 2.12

Spectrum of disease in macaque monkeys chronically infected with SIV/SMM. Vet Immunol Immunopathol (1989) 2.09

A molecular clone of HIV-1 tropic and cytopathic for human and chimpanzee lymphocytes. Virology (1993) 1.83

The natural history of infection with the lymphadenopathy-associated virus/human T-lymphotropic virus type III. Ann Intern Med (1985) 1.71

A distinct African lentivirus from Sykes' monkeys. J Virol (1993) 1.58

Components of saliva inactivate human immunodeficiency virus. Lancet (1986) 1.39

Vaginal transmission of human immunodeficiency virus (HIV) to a chimpanzee. J Infect Dis (1986) 1.38

Isolation from African Sykes' monkeys (Cercopithecus mitis) of a lentivirus related to human and simian immunodeficiency viruses. J Virol (1991) 1.38

SIV from stump-tailed macaques: molecular characterization of a highly transmissible primate lentivirus. Virology (1992) 1.29

Wild-type isopropylmalate isomerase in Salmonella typhimurium is composed of two different subunits. J Bacteriol (1981) 1.24

Early pathogenesis of disease caused by SIVsmmPBj14 molecular clone 1.9 in macaques. AIDS Res Hum Retroviruses (1993) 1.14

A chimpanzee-passaged human immunodeficiency virus isolate is cytopathic for chimpanzee cells but does not induce disease. J Virol (1991) 1.12

Mucosal immune system of the human genital tract. J Infect Dis (1999) 1.10

Genetic differences accounting for evolution and pathogenicity of simian immunodeficiency virus from a sooty mangabey monkey after cross-species transmission to a pig-tailed macaque. J Virol (1992) 1.06

Immune activation and viral burden in acute disease induced by simian immunodeficiency virus SIVsmmPBj14: correlation between in vitro and in vivo events. J Virol (1994) 1.05

Genital infection of female chimpanzees with human immunodeficiency virus type 1. AIDS Res Hum Retroviruses (1998) 1.01

Nonhuman primate models for evaluation of AIDS therapy. Ann N Y Acad Sci (1990) 1.01

Salmonella typhimurium newD and Escherichia coli leuC genes code for a functional isopropylmalate isomerase in Salmonella typhimurium-Escherichia coli hybrids. J Bacteriol (1979) 1.00

Loss of CD4+ T cells in human immunodeficiency virus type 1-infected chimpanzees is associated with increased lymphocyte apoptosis. J Virol (1998) 0.98

New approaches for mucosal vaccines for AIDS: encapsidation and serial passages of poliovirus replicons that express HIV-1 proteins on infection. AIDS Res Hum Retroviruses (1994) 0.98

Extensive diversification of human immunodeficiency virus type 1 subtype B strains during dual infection of a chimpanzee that progressed to AIDS. J Virol (1998) 0.96

Down-regulation of macaque gammadelta + T cells in lymphoid compartments after rectal infection with SIVsmmPBj14. J Med Primatol (2000) 0.96

Genetic analysis of resistance to lethal infections of vesicular stomatitis virus in Syrian hamsters. Infect Immun (1981) 0.94

The U3 promoter region of the acutely lethal simian immunodeficiency virus clone smmPBj1.9 confers related biological activity on the apathogenic clone agm3mc. Proc Natl Acad Sci U S A (1995) 0.90

Allelic variants of human beta-chemokine receptor 5 (CCR5) promoter: evolutionary relationships and predictable associations with HIV-1 disease progression. Genes Immun (1999) 0.90

An acutely lethal simian immunodeficiency virus stimulates expansion of V beta 7- and V beta 14-expressing T lymphocytes. Proc Natl Acad Sci U S A (1994) 0.89

Poliovirus replicons that express the gag or the envelope surface protein of simian immunodeficiency virus SIV(smm) PBj14. Virology (1996) 0.89

Molecular and biological analyses of quasispecies during evolution of a virulent simian immunodeficiency virus, SIVsmmPBj14. J Virol (1995) 0.89

Enhanced responsiveness to nuclear factor kappa B contributes to the unique phenotype of simian immunodeficiency virus variant SIVsmmPBj14. J Virol (1994) 0.89

Cell-mediated immune proliferative responses to HIV-1 of chimpanzees vaccinated with different vaccinia recombinant viruses. AIDS Res Hum Retroviruses (1989) 0.88

Construction and characterization of Salmonella typhimurium strains that accumulate and excrete alpha- and beta-isopropylmalate. J Bacteriol (1980) 0.88

Requirements for simian immunodeficiency virus antigen-specific in vitro proliferation of T cells from infected rhesus macaques and sooty mangabeys. AIDS (1990) 0.86

Phenotypic and functional differences in NK and LAK cells in the peripheral blood of sooty mangabeys and rhesus macaques. Cell Immunol (1989) 0.85

Loss of the SIVsmmPBj14 phenotype and nef genotype during long-term survival of macaques infected by mucosal routes. Virology (1997) 0.85

Mediators of protection against lethal systemic vesicular stomatitis virus infection in hamsters: defective interfering particles, polyinosinate-polycytidylate, and interferon. Infect Immun (1982) 0.85

Failure of a human immunodeficiency virus type 1 (HIV-1) subtype B-derived vaccine to prevent infection of chimpanzees by an HIV-1 subtype E strain. J Virol (1996) 0.84

Molecular clones from a non-acutely pathogenic derivative of SIVsmmPBj14: characterization and comparison to acutely pathogenic clones. AIDS Res Hum Retroviruses (1992) 0.84

Involvement of cells of hematopoietic origin in genetically determined resistance of Syrian hamsters to vesicular stomatitis virus. Infect Immun (1981) 0.83

HIV-1/simian immunodeficiency virus infection of human and nonhuman primate lymphocytes results in the migration of CD2+ T cells into the intestine of engrafted SCID mice. J Immunol (1998) 0.83

Challenge of chimpanzees immunized with a recombinant canarypox-HIV-1 virus. Virology (1997) 0.82

Maternal transmission of SIVsmm in rhesus macaques. J Med Primatol (1991) 0.82

Evidence for a lentiviral etiology in an epizootic of immune deficiency and lymphoma in stump-tailed macaques (Macaca arctoides). J Med Primatol (1992) 0.81

Detection of simian T cell leukemia virus type I infection in seronegative macaques. AIDS Res Hum Retroviruses (1997) 0.81

Immune response of chimpanzees after immunization with the inactivated whole immunodeficiency virus (HIV-1), three different adjuvants and challenge. Vaccine (1993) 0.79

Differing responses of hamsters to infection by vesicular stomatitis virus Indiana and New Jersey serotypes. Virus Res (1985) 0.79

Vesicular stomatitis virus can establish persistent infections in Syrian hamsters. J Gen Virol (1982) 0.79

Polynucleotide immunization of nonhuman primates against carcinoembryonic antigen. Clin Cancer Res (1998) 0.78

Retrovirus serology and Kawasaki syndrome. Lancet (1987) 0.78

Distribution and quantification of human immunodeficiency virus type 1, strain JC499, proviral DNA in tissues from an infected chimpanzee. Virology (2000) 0.78

Characterization and titration of an HIV type 1 subtype E chimpanzee challenge stock. AIDS Res Hum Retroviruses (1997) 0.77

IgA immunity in HIV type 1-infected chimpanzees. I. Systemic immunity. AIDS Res Hum Retroviruses (1997) 0.77

Virus-specific cytotoxic T lymphocytes in human immunodeficiency virus type 1-infected chimpanzees. J Virol (1999) 0.77

The FeLV and SIV AIDS pathogenesis models: search for and analysis of molecularly defined pathogens. Dev Biol Stand (1990) 0.77

IgA immunity in HIV type 1-infected chimpanzees. II. Mucosal immunity. AIDS Res Hum Retroviruses (1997) 0.77

HIV type 1 strains pathogenic for chimpanzees. AIDS Res Hum Retroviruses (1997) 0.76

Down-modulation of the ZAP-70 protein tyrosine kinase in macaque T lymphocytes infected with SIVsmmPBj14. J Med Primatol (1998) 0.75

Novel alleles at the lymphotoxin alpha (LTalpha) locus mark extended HLA haplotypes in native Africans. Hum Immunol (2001) 0.75

Fine specificity of anti-V3 antibodies induced in chimpanzees by HIV candidate vaccines. AIDS Res Hum Retroviruses (1998) 0.75

Genetically determined resistance to lethal vesicular stomatitis virus in syrian hamsters. Adv Exp Med Biol (1981) 0.75

Human and nonhuman primate lymphocytes engrafted into SCID mice reside in unique mesenteric lymphoid structures. J Immunol (1998) 0.75

Effects of prostaglandin E2 on replication of HIV-1 in human peripheral blood mononuclear cells. AIDS (1991) 0.75

Severe combined immunodeficient mice engrafted with macaque peripheral blood leukocytes support replication of SIVsmm. AIDS Res Hum Retroviruses (1998) 0.75